Detalhe da pesquisa
1.
A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer.
Anticancer Drugs
; 23(5): 543-52, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22481061
2.
Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer.
Prostate
; 70(13): 1437-47, 2010 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20687217
3.
Assessing the therapeutic and toxicological effects of cesium chloride following administration to nude mice bearing PC-3 or LNCaP prostate cancer xenografts.
Cancer Chemother Pharmacol
; 60(6): 821-9, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17294190
4.
Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.
Cancer Chemother Pharmacol
; 64(6): 1085-95, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19301006
5.
Evaluation of the antiproliferative effects of Essiac on in vitro and in vivo models of prostate cancer compared to paclitaxel.
Nutr Cancer
; 58(2): 188-96, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17640165
6.
Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models.
J Urol
; 175(5): 1926-31, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16600800
7.
Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors.
J Urol
; 174(2): 636-41; discussion 641; quiz 801, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16006928
8.
Bioactive compounds from Rhodiola rosea (Crassulaceae).
Phytother Res
; 19(9): 740-3, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16220564
9.
Detection of mRNA degradation intermediates in tissues using the 3'-end poly(A)-tailing polymerase chain reaction method.
Anal Biochem
; 335(1): 58-65, 2004 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15519571